Table 1.
Characteristics of Study Participants Selected for Loop-Mediated Isothermal Amplification, by Human Immunodeficiency Virus (HIV) Status
| Characteristic | HIV Uninfected (n = 4000) | HIV Infected (n = 131) |
|---|---|---|
| Age, y | 16 (7–40) | 40 (31–50) |
| Female sex | 2094 (52.4) | 89 (67.9) |
| cART and HIV VL statusa | ||
| Receiving cART, undetectable load | NA | 107 (81.7) |
| Receiving cART, detectable load | NA | 13 (9.9) |
| Not receiving cART, detectable load | NA | 9 (6.9) |
| HIV VL (if detectable)a | NA | 56 506 (5904–168 661) |
| CD4+ T-cell count, cells/µLa | ||
| ≥500 | NA | 76 (58.0) |
| 200–499 | NA | 46 (35.1) |
| <200 | NA | 7 (5.3) |
| Overall | NA | 559 (402–783) |
Data are median (interquartile range) or no. (%) of subjects.
Abbreviations: cART, combination antiretroviral therapy; NA, not applicable; VL, viral load.
a Data are missing for 2 participants.